Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1) (TRILOGY 1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03398005
Recruitment Status : Active, not recruiting
First Posted : January 12, 2018
Last Update Posted : July 15, 2019
Sponsor:
Information provided by (Responsible Party):
Acasti Pharma Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : July 2019
Estimated Study Completion Date : November 2019